1. Home
  2. BLLN vs ESAB Comparison

BLLN vs ESAB Comparison

Compare BLLN & ESAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$97.55

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo ESAB Corporation

ESAB

ESAB Corporation

HOLD

Current Price

$87.56

Market Cap

5.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
ESAB
Founded
2016
1904
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Office Equipment/Supplies/Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.6B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BLLN
ESAB
Price
$97.55
$87.56
Analyst Decision
Buy
Strong Buy
Analyst Count
7
9
Target Price
$126.71
$138.56
AVG Volume (30 Days)
784.7K
576.4K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
0.42%
EPS Growth
N/A
N/A
EPS
N/A
1.27
Revenue
N/A
$2,842,555,000.00
Revenue This Year
$46.29
$6.21
Revenue Next Year
$30.14
$5.33
P/E Ratio
N/A
$72.33
Revenue Growth
N/A
3.71
52 Week Low
$61.96
$82.19
52 Week High
$150.44
$137.42

Technical Indicators

Market Signals
Indicator
BLLN
ESAB
Relative Strength Index (RSI) 36.52 46.10
Support Level $73.46 $82.55
Resistance Level $108.50 $94.18
Average True Range (ATR) 8.11 4.22
MACD -5.41 0.64
Stochastic Oscillator 13.69 28.51

Price Performance

Historical Comparison
BLLN
ESAB

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About ESAB ESAB Corporation

ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.8 billion in revenue in 2025.

Share on Social Networks: